ICD10

DeepScribe Deepens Integration with Epic, Laying Groundwork for Future Ambient Solutions

Retrieved on: 
Thursday, January 11, 2024

SAN FRANCISCO, Jan. 11, 2024 /PRNewswire/ -- DeepScribe, the leading enterprise-grade AI medical scribe, today announced key updates to its integration with Epic Systems' electronic health record (EHR). DeepScribe's recently launched Customization Studio, which allows users to build custom models to support unique specialty and organizational needs, is now fully integrated with Epic's SmartData elements. This makes DeepScribe the first solution to harmonize an extensive suite of customization options with Epic's interface and establishes a new benchmark for ambient solutions on their platform.

Key Points: 
  • This makes DeepScribe the first solution to harmonize an extensive suite of customization options with Epic's interface and establishes a new benchmark for ambient solutions on their platform.
  • Developed in close partnership with Epic and DeepScribe customer Covenant HealthCare, improvements to DeepScribe's integration were shaped by feedback from clinicians, technical experts, and organizational stakeholders.
  • This user-first approach allows DeepScribe to push highly personalized documentation directly into the discrete fields of a patient's chart.
  • By introducing SmartData compatibility, DeepScribe is not only enhancing its user-friendly build but paving the way for other ambient solutions to follow suit.

New Data Show 35% of All Weight Loss Drugs are Prescribed by NPs and PAs

Retrieved on: 
Tuesday, October 3, 2023

BOONTON, N.J., Oct. 3, 2023 /PRNewswire/ -- POCN Group, the premier strategic consulting agency for pharma and life sciences focused on Nurse Practitioners (NPs) and Physician Associates (PAs), unveils new groundbreaking data highlighting the current landscape of weight loss drug prescribing. According to the latest proprietary data analysis from POCN Group, NPs and PAs are emerging as important contributors to obesity drug prescribing, responsible for 35 percent of all weight loss drugs, an increase from 28 percent in 2022.

Key Points: 
  • BOONTON, N.J., Oct. 3, 2023 /PRNewswire/ -- POCN Group , the premier strategic consulting agency for pharma and life sciences focused on Nurse Practitioners (NPs) and Physician Associates (PAs), unveils new groundbreaking data highlighting the current landscape of weight loss drug prescribing.
  • According to the latest proprietary data analysis from POCN Group, NPs and PAs are emerging as important contributors to obesity drug prescribing, responsible for 35 percent of all weight loss drugs, an increase from 28 percent in 2022.
  • This surge in weight loss drug prescriptions by NPs and PAs fueled by recent injectable entrants to the market represents a remarkable and often underestimated opportunity for pharmaceutical companies looking to expand their reach.
  • "For pharmaceutical companies, the rise of NPs and PAs in prescribing weight loss drugs represents an exciting paradigm shift," said Richard Zwickel, CEO of POCN Group.

With reimbursement under threat, MedLearn delivers actionable guidance with unprecedented All-Access Passes and webcast subscriptions

Retrieved on: 
Wednesday, June 14, 2023

ST. PAUL, Minn., June 14, 2023 /PRNewswire-PRWeb/ -- With the great resignation creating knowledge gaps, Medicare reimbursement constantly under the threat of reduction, coding complexities, and endless opportunities for errors, reimbursement faces exceptional challenges making facilities across the nation vulnerable to financial losses. Even more, with the end of public health emergency and the storm of policy changes that took place, it's only a matter of time before auditors are expected to dig into compliance issues with targeted scrutiny. MedLearn Media continues innovating multiple product lines to meet the demands of uncertain times giving professionals the tools to adapt to the evolving healthcare regulatory landscape. Expert-guided content fast-tracks answers through a variety of options with unlimited access to comprehensive sets of educational and reference resources, along with webcast subscriptions for one affordable annual fee.

Key Points: 
  • MedLearn Media's All-Access Passes and webcast subscriptions offer unparalleled coding and compliance support in the face of reimbursement threats.
  • "The decision to develop All-Access Passes and subscriptions was inspired by the growing demand for comprehensive and convenient access to industry resources and information.
  • "All-Access Passes and subscriptions provide a centralized platform where users can access a wealth of valuable content and services in one place.
  • MedLearn Media offers multiple All-Access Pass options and webcast subscriptions to fit any size organization, team, and budget, including a 7-day free trial for ICD10 and RAC monitor webcast subscriptions.

Artificial Medical Intelligence Healthcare Platform Saves Time and Money

Retrieved on: 
Monday, February 27, 2023

MARLBORO, N.J., Feb. 27, 2023 /PRNewswire/ -- On December 3, 2022, Artificial Medical Intelligence (AMI) celebrated 20 years of innovation in healthcare as it continues to expand its cadre of proven use cases covering the healthcare and health insurance verticals.

Key Points: 
  • MARLBORO, N.J., Feb. 27, 2023 /PRNewswire/ -- On December 3, 2022, Artificial Medical Intelligence (AMI) celebrated 20 years of innovation in healthcare as it continues to expand its cadre of proven use cases covering the healthcare and health insurance verticals.
  • The technology coding platform is available through AMI's User Interface, or through a robust interoperable Application Protocol Interface.
  • "AMI celebrates its 20 years with a real, scalable and configurable platform through a time-tested technology foundation driven by industry experience.
  • For more information on AMI's innovative healthcare platform, please contact:

Expert.ai Announces New Features to Hybrid Natural Language Platform

Retrieved on: 
Tuesday, February 7, 2023

BOSTON, Feb. 7, 2023 /PRNewswire/ -- Expert.ai  (EXAI:IM), a leading company in artificial intelligence (AI) for language understanding and language operations, announces today the release of new features for its Natural Language (NL) platform enhancing purpose-built natural language processing (NLP) workflow support. By employing a hybrid approach that combines state of the art in NL techniques – including machine learning and knowledge-based, symbolic AI – the expert.ai Platform gets the most out of unstructured data, like text in documents, applications and tools, to enable organizations create new business models, accelerate time to value and optimize processes.

Key Points: 
  • BOSTON, Feb. 7, 2023 /PRNewswire/ -- Expert.ai (EXAI:IM), a leading company in artificial intelligence (AI) for language understanding and language operations, announces today the release of new features for its Natural Language (NL) platform enhancing purpose-built natural language processing (NLP) workflow support.
  • Natural language text understanding has advanced to among the most widely embedded AI capabilities within organizations.
  • According to Forrester*, "Hybrid AI delivers the best results for NLP Applications... Human knowledge remains essential for many use cases, including the effective use of natural language processing (NLP)."
  • Expert.ai's hybrid NL Platform analyzes and understands unstructured language data in vertical domains to accelerate business impact.

Aspen Insights and RealTime-CTMS Announce Partnership to Streamline Clinical Research Recruitment Workflows

Retrieved on: 
Thursday, October 6, 2022

This powerful integration includes:

Key Points: 
  • This powerful integration includes:
    Candidate identification by searching patient medical records and clinical data that exceeds standard EMR search capabilities (i.e.
  • Pre-qualified and physician-confirmed delivery of study candidates into RealTime-CTMS to manage the recruitment and enrollment processes and track the patient's research journey.
  • "We are excited to bring our highly effective and proven EMR/EHR database mining technology to clinical research investigative sites to help solve one of the greatest challenges that the clinical research industry is faced with, effective and timely study recruitment," said Aspen Insights' CEO Walter Storm.
  • RealTime Software Solutions, LLC provides innovative software products for clinical trial research sites, site networks, sponsors and CROs to manage complex clinical research processes with powerful, user-friendly interfaces that are revolutionizing how research gets done.

Aspen Insights Joins athenahealth's Marketplace Program to Streamline Patient Recruitment and Increase Clinical Trial Enrollment

Retrieved on: 
Thursday, September 22, 2022

FORT WORTH, Texas, Sept. 22, 2022 /PRNewswire/ -- Aspen Insights, a technology firm focused on bringing innovative medical treatments to patients by streamlining the clinical research recruitment process, today announced a partnership with athenahealth, Inc. As part of the athenahealth® Marketplace, this newly integrated application, Aspen Forge, is now available to athenahealth's growing network of practices to assist those conducting clinical research with accurately projecting enrollment feasibility metrics and identifying qualified candidates, such that hours to perform manual chart review are significantly decreased and enrollment skyrockets.

Key Points: 
  • "In a time when trial recruitment is becoming increasingly more complex, new technologies, like Aspen Forge, are being recognized as key solutions able to increase enrollment outcomes.
  • As a Marketplace partner, Aspen Insights joins a community of innovative, like-minded healthcare professionals working to bring best-in-class solutions to the athenahealth provider base.
  • To learn more about Aspen Insights' new integrated application, Aspen Forge, please Aspen Insights' listing page on the Marketplace.
  • Customers use Marketplace partner solutions to boost practice efficiency, increase patient satisfaction, and engage patients in their own care.

Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix

Retrieved on: 
Monday, July 25, 2022

Thousands of healthcare providers (HCPs) already rely on Arkstone's OneChoice report and its innovative and informative overreads of laboratory results.

Key Points: 
  • Thousands of healthcare providers (HCPs) already rely on Arkstone's OneChoice report and its innovative and informative overreads of laboratory results.
  • "There is no substitute for the OneChoice Report,'' explains Dr. Ari Frenkel, Chief Sciences Officer, Co-Founder of Arkstone and infectious disease physician.
  • Pregnancy consideration is included with every OneChoice report and is automatically incorporated into the services provided by Arkstone.
  • The MedsMatrixis available with every OneChoice report via the OneChoice Plus accessed by scanning the QR code found on each OneChoice Report with a mobile device or by clicking the QR code link.

Talk Ten Tuesdays 500th Episode - Q&A with Chuck Buck

Retrieved on: 
Tuesday, March 15, 2022

So, we started ICD10 Monitor in 2011 and began the broadcast , "Talk Ten Tuesdays," reporting on ICD-10, so that's the genesis of Talk Ten Tuesday.

Key Points: 
  • So, we started ICD10 Monitor in 2011 and began the broadcast , "Talk Ten Tuesdays," reporting on ICD-10, so that's the genesis of Talk Ten Tuesday.
  • Chuck: The biggest challenge and I don't think I'm alone in this is trying to understand the anatomy involved.
  • I can talk about body parts at a cocktail party now for about five minutes and sound pretty authoritative.
  • Chuck: That's a subject we talk about frequently on ICD10 Monitor and Talk Ten Tuesday.

NoviSystems Launches Fusion Analytics Platform For Data-Driven Benefits In Health Care And Rare Disease Management, Drug Manufacturing

Retrieved on: 
Wednesday, October 20, 2021

Anyone familiar with a pivot table in Microsoft's Excel software should be able to apply Fusion Analytics to their organizations.

Key Points: 
  • Anyone familiar with a pivot table in Microsoft's Excel software should be able to apply Fusion Analytics to their organizations.
  • Fusion Analytics is well suited for complex businesses in health care such as hospitals, biopharmaceutical and pharmaceutical manufacturers, and contract research organizations.
  • Daughtry is a past trustee of the Florida-based Phelan-McDermid Syndrome Foundation, a rare disease nonprofit organization, and a leading business consultant.
  • Since the inception of the Rare Disease InfoHub, leaders in the rare disease community like Daughtry have ensured that academic and commercial Fusion Analytics projects meet the needs of patients and families.